In situ SAXRD study of sol-gel induced well-ordered mesoporous bioglasses for drug delivery

Journal of Biomedical Materials Research - Part A

Volumn 85, Issue 4, 2008, Pages 1032-1042

  Zhao, Y F ^a   Loo, S C J ^a   Chen, Y Z ^a   Boey, F Y C ^a   Ma, J ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Bioactivity; Bioglass; Drug release; Mechanism; Mesoporous

Indexed keywords

BLOCK COPOLYMERS; DRUG DELIVERY; SOL-GEL PROCESS; X RAY DIFFRACTION ANALYSIS;

DRUG LOADING; MESOPOROUS BIOGLASSES; ORDERED STRUCTURE;

BIOACTIVE GLASS;

CALCIUM; GLASS; METOCLOPRAMIDE; OXYGEN; PHOSPHORUS; POLOXAMER; SILICON;

ARTICLE; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; DRUG RELEASE; PHASE TRANSITION; POROSITY; RIGIDITY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

APATITES; CERAMICS; DRUG DELIVERY SYSTEMS; GELS; METOCLOPRAMIDE; MICROSCOPY, ELECTRON, TRANSMISSION; POROSITY; SCATTERING, SMALL ANGLE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 44149107962     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31545     Document Type: Article

References (36)

1. IUPAC manual of symbols and terminology, appendix 2, Part I: Colloid and surface chemistry. Pure Appl Chem 1972;31:578-563.
2. Selvam P, Bhatia SK, Sonwane, CG. Recent advances in processing and characterization of periodic mesoporous MCM-41 silicate molecular sieves. Ind Eng Chem Res 2001;40:3237-3261.
3. Xia W, Chang J. Well-ordered mesoporous bioactive glasses (MBG): A promising bioactive drug delivery system. J Control Release 2006;110:522-530.
4. Zhao YF, Ma J. Triblock co-polymer templating synthesis of mesostructured hydroxyapatite. Micropor Mesopor Mater 2005;87:110-117.
5. Andersson J, Areva S, Spliethoff B, Lindén M. Sol-gel synthesis of multifunctional hierarchial porous silica/apatite composite. Biomaterials 2005;26:6827-6835.
6. Mollo L, Levresse V, Ottaviani M, Ellouk-Achard S, Jaurand M.-C, Fubini B. Study of the stability of a paramagnetic label linked to mesoporous silica surface in contact with rat mesothelial cells in culture. Environ Health Perspect 1997;105:1031-1036.
7. Vallet-Regi M, Ramila A, del Real RP, Perez-Pariente J. A new property of MCM-41: Drug delivery system. Chem Mater 2001;13:308-311.
8. Charnay C, Bégu S, Tourné-Péteilh C, Nicole L, Lerner DA. Inclusion of ibuprofen in mesoporous templated silica: Drug loading and release property. Euro J Pharm Biopharm 2004;57:533-540.
9. Huo Q, Margolese DI, Ciesla U, Feng P, Sieger P, Gier TE, Leon R, Petroff PM, Schuth F, Stucky GD. Generalized syntheses of periodic surfactant/inorganic composite materials. Nature 1994;368:317-321.
10. Mintova S, Olson NH, Valtchev V, Bein T. Mechanism of zeolite A nanocrystal growth from colloids at room temperature. Science 1999;283:958-960.
11. Beck JS, Vartuli JC, Roth WJ, Leonowicz ME, Kresge CT, Schmitt KD, Chu CTW, Olson DH, Sheppard EW, McCullen SB, Higgins JB, Schlenker JL. A new family of mesoporous molecular sieves prepared with liquid crystal templates. J Am Chem Soc 1992;114:10834-10843.
12. Hoinkis E, Röhl-Kuhn BJ. In situ small-angle neutron scattering study of nitrogen adsorption and condensation in mesoporous silica glass CPG-10-75. Coll Interf Sci 2006;296:256-262.
13. Zara R, Frasch J, Soulard M, Lebeau B, Patarin J. Fluorescence probing investigations of the mechanism of formation of organized mesoporous silica. Langmuir 1999;15:2603-2606.
14. Kirsch BL, Richman EK, Riley AE, Tolbert SH. In-situ X-ray diffraction study of the crystallization kinetics of mesoporous titania films. J Phys Chem B 2004;108:12698-12706.
15. Tolbert SH, Landry CC, Stucky GD. Phase transitions in mesostructured silica/surfactant composites: Surfactant packing and the role of charge density matching. Chem Mater 2001;13:2247-2256.
16. Flodström K, Teixeira CV, Amenitsch H, Alfredsson V, Lindén M. In situ-synchrotron small-angle X-ray scattering/X-ray diffraction study of the formation of SBA-15 mesoporous silica. Langmuir 2004;20:4885-4891.
17. Hench LL, Splinter BJ, Allen WC, Greenlee TK. Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Mater Res 1971;2:117-141.
18. Wilson J, Yli-Urpo A, Risto-Pekka H. Bioactive glasses: Clinical applications. In: Hench LL, Wilson J, editors. An Introduction to Bioceramics. Singapore: World Scientific; 1993. p 63-74.
19. Yamamuro T. A/W glass-ceramic: Clinical applications. In: Hench, LL, Wilson J, editors. An Introduction to Bioceramics. Singapore: World Scientific; 1993. p 89-104.
20. Sakka SJ. Glasses and glass-ceramics from gels. Non-Cryst Solids 1985;73:651-660.
21. Li R, Clark AE, Hench LL. An investigation of bioactive glass powders by sol-gel processing. J Appl Biomater 1991;2:231-239.
22. Hench LL. Stability of ceramics in the physiological environment. In: Williams DF, editor. Fundamental Aspects of Biocompatibility. Boca Raton: CRC Press; 1981. p 67-85.
23. Yan XX, Yu CH, Zhou XF, Tang JW, Zhao DY. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. Angew Chem Int Ed 2004;43:5980-5984.
24. Wang XT, Venkatraman S, Boey F, Loo SCJ, Tan LP. Controlled release of sirolimus from a multi layered PLGA stent matrix. Biomaterials 2006;27:5588-5595.
25. Pan J, Venkatraman SS, Feng M, Boey YCF, Gan LH. Micelle-like nanoparticles of star-branched PEG-PLA copolymers as chemotherapeutic carrier. J Control Release 2005;110:20-33.
26. Alexis F, Venkatraman SS, Rath SK, Boey F. In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices. J Control Release 2004;98:67-74.
27. Alexis F, Boey F, Rath S, Venkatraman S. Study of the initial stages of drug release from a degradable matrix of poly(D,L-lactide -co-glycolide). Biomaterials 2004;25:813-821.
28. Pereira MM, Clark AE, Hench LL. Calcium phosphate formation on sol-gel derived bioactive glasses in vitro. J Biomed Mater Res 1994;28:693-698.
29. Laczka M, Cholewa-Kowalska K, Laczka-Osyczka A, Tworzydlo M, Turyna B. Gel-derived materials of a CaO-P2O5-SiO2 system modified by boron, sodium, magnesium, aluminum, and fluorine compounds. J Biomed Mater Res 2000;52:601-612.
30. Sampath SS, Robinson DH. Comparison of new and existing spectrophotometric methods of analysis of tobramycin and other aminoglycosides. J Pharm Sci 1990;79:428-431.
31. Zhao DY, Feng JL, Huo QS, Melosh N, Fredrickson GH, Chmelka BF, Stucky GD. Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 1998;279:548-552.
32. Feng PY, Bu XH, Pine DJ. Control of pore sizes in mesoporous silica templated by liquid crystals in block copolymer-cosurfactant-water systems. Langmuir 2000;16:5304-5310.
33. Goltner-Spickermann C. Non-ionic templating of silica: Formation mechanism and structure. Curr Opin Coll Interf Sci 2002;7:173-178.
34. Hench LL, West JK. Biological applications of bioactive glasses. Life Chem Rep 1996;13:187-241.
35. Kokubo T, Kushitani H, Sakka S. Solutions able to reproduce in vivo surface-structure changes in bioactive glass ceramic A-W. J Biomed Mater Res 1990;24:721-734.
36. Kokubo T. A/W glass ceramics: processing and properties. In: Hench LL, Wilson J, editors. Introduction to bioceramics. Singapore: World Scientific; 1993. p 75-88.